PhRMA
MARCH 6, 2025
Lawmakers on both sides of the aisle are renewing a multi-year effort to crack down on drug middlemen, known as pharmacy benefit managers (PBMs). These middlemen control what patients pay at the pharmacy counter, where they can get their medicine, what medicines they can get and what hoops they must jump through. The effort in Congress reflects mounting pressure to hold PBMs accountable and help lower patients’ out-of-pocket costs.
Drug Topics
MARCH 6, 2025
Researchers conducted a survey asking pharmacists their perspectives on addressing patients social determinants of health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MARCH 6, 2025
Policymakers and health care providers call for reforms to improve transparency, pricing, and patient access.
Drug Topics
MARCH 6, 2025
The approval is the first significant innovation for the delivery of epinephrine for this population in more than 35 years, according to the company news release.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MARCH 6, 2025
Elevidys offers significantly higher dystrophin production than existing Duchenne muscular dystrophy treatments but requires intensive monitoring for adverse events.
Drug Topics
MARCH 6, 2025
Cebranopadol met its primary endpoint of reduction in pain intensity as measured by the Pain Numeric Rating Scale (NRS) area under the curve from 2 through 48 hours.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
MARCH 6, 2025
Currently, there is a gap in treatment for this patient population and intracerebral hemorrhagic stroke is considered an orphan disease.
Oswald's
MARCH 6, 2025
While the retail pharmacy landscape continues to see independent locations shutter, were continuing to do everything we can to stay afloat and continue serving our wonderful community. As weve seen our customer base grow over the past year, Id love to share a quick history of my family & Oswalds past. The pharmacy’s journey began with my great-great-great grandfather, William Wallace Wickel.
Drug Topics
MARCH 6, 2025
The Cut Hypertension Program operates in barbershops across the Bay Area in California. The programs lead pharmacist joined us to discuss main themes and goals of the new initiative.
Fierce Healthcare
MARCH 6, 2025
Private equity firm Sycamore Partners has entered into a definitive agreement with Walgreens Boots Alliance to acquire the struggling retail pharmacy chain. | The confirmation follows weeks of speculation and rumors that Sycamore was planning to take over Walgreens and take the company private.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
MARCH 6, 2025
The M&A resurgence has been predicted for years, but the industry is still holding out, partly because the ideal range for biotech valuations has been harder to find.
Pharmacy Times
MARCH 6, 2025
Melatonin supplementation could improve oxidative DNA damage repair capacity among night shift workers.
Pharma Marketing Network
MARCH 6, 2025
Introduction Pharmaceutical marketing has evolved. Traditional advertising methods alone no longer cut it in todays digital-first world. Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers.
Pharmacy Times
MARCH 6, 2025
With the new designation, OpCT-001 can receive expedited investigations into its potential to improve vision function in patients with primary photoreceptor diseases.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Oswald's
MARCH 6, 2025
As we anticipate the beginning of the Spring season, most of us start thinking about cleaning and decluttering our homes, planting our gardens, or planning how to keep our children busy over spring break. We should also be thinking about cleaning or detoxing our body, more specifically, our liver. Our liver is an essential organ and plays a vital role in sustaining life.
Pharmacy Times
MARCH 6, 2025
Panelists discuss how antibody-drug conjugates (ADCs) for breast cancer (BC) differ in their safety profiles, with trastuzumab deruxtecan (T-DXd) having notable interstitial lung disease risk, sacituzumab govitecan (SG) associated with neutropenia/diarrhea, and datopotamab deruxtecan (Dato-DXd) showing a relatively favorable safety profile but still requiring monitoring.
Fierce Healthcare
MARCH 6, 2025
A coalition of industry organizations is pressing employers to offer coverage for obesity as they would for other chronic conditions. | A coalition of industry organizations is pressing employers to offer coverage for obesity as they would for other chronic conditions.
pharmaphorum
MARCH 6, 2025
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a conversation on how generative AI is revolutionising life sciences and drug development.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
MARCH 6, 2025
The agency told hospitals Wednesday they are obligated to adhere to the highest standard of care and implied that hormonal treatments and surgical procedures for gender-affirming care do not meet that bar.
Pharmacy Times
MARCH 6, 2025
According to a news release, this marks the first significant innovation in epinephrine delivery for this patient population is more than 35 years.
Fierce Healthcare
MARCH 6, 2025
The Peterson Health Technology Institute is set to begin evaluating virtual care programs for opioid use disorder, examining clinical effectiveness and economic effects.
Pharmacy Times
MARCH 6, 2025
A brief period of overeating ultra-processed, high-calorie snacks could lead to liver fat accumulation and temporary disruption of brain insulin action.
pharmaphorum
MARCH 6, 2025
Novo Nordisk has launched direct-to-consumer sales of its obesity drug Wegovy for uninsured or under-insured people at $499 per month.
Pharmacy Times
MARCH 6, 2025
The treatment's expanded indication for chronic kidney disease (CKD) is expected to be available by April 2025.
Pharmaceutical Technology
MARCH 6, 2025
Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.
Pharmacy Times
MARCH 6, 2025
Efficacy and tolerability of topical treatments can vary by region, particularly sensitive areas such as the face and neck.
Pharmaceutical Technology
MARCH 6, 2025
FDA has granted approval for ARS Pharmaceuticals' neffy 1mg for treating anaphylaxis in paediatric patients.
Pharmacy Times
MARCH 6, 2025
The move is expected to expand clozapine access for patients with schizophrenia.
Fierce Healthcare
MARCH 6, 2025
The new platform is a result of Datavants acquisition of Apixios connected care platform and value-based care solution in September 2024. The Apixio brand will sunset.
Pharmacy Times
MARCH 6, 2025
Specialty pharmacists are critical for enhanced management of clinical and logistical aspects of treatment.
pharmaphorum
MARCH 6, 2025
XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare
Pharmacy Times
MARCH 6, 2025
At 1- and 2-year follow-up points, ruxolitinib led to considerable improvements in survival in patients with myelofibrosis who develop graft-versus-host disease (GVHD).
pharmaphorum
MARCH 6, 2025
Days after NHS England CEO Amanda Pritchard resigned, national medical director Prof Sir Stephen Powis has also said he will also step down.
Expert insights. Personalized for you.
179 
Let's personalize your content